Stockscreener 앱 받기
1.67
0.00%
0.00
시장 영업 전:
1.63
-0.04
-2.40%
전일 마감가:
$1.67
열려 있는:
$1.64
하루 거래량:
351.80K
Relative Volume:
0.26
시가총액:
$43.44M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.60%
1개월 성능:
-38.38%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$1.60
$1.69
1주일 범위
$1.40
$1.71
52주 변동 폭
$1.12
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
명칭
Liminatus Pharma Inc
전화
213-273-5453
주소
6 CENTERPOINTE DR., LA PALMA
LIMN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
1.67 | 45.20M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스
Candlestick signals on Liminatus Pharma Inc. Equity Warrant stock todayWeekly Investment Report & AI Enhanced Trade Execution Alerts - newser.com
Risk adjusted return profile for Liminatus Pharma Inc. analyzedMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - newser.com
Published on: 2025-09-30 05:51:02 - newser.com
Will Liminatus Pharma Inc. Equity Warrant stock outperform value stocksInflation Watch & Weekly Stock Performance Updates - newser.com
Using flow based indicators on Liminatus Pharma Inc. Equity Warrant2025 Technical Overview & Stock Portfolio Risk Management - newser.com
Is Liminatus Pharma Inc. stock attractive for income investorsJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Is Liminatus Pharma Inc. Equity Warrant stock attractive for growth ETFsJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
How Liminatus Pharma Inc. Equity Warrant stock performs in weak economyVolume Spike & Technical Confirmation Trade Alerts - newser.com
Sempra Stock Analysis and ForecastLarge Cap Stability Picks & Low Risk Investment Portfolio - earlytimes.in
Is Liminatus Pharma Inc. stock positioned well for digital economyJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
Is Liminatus Pharma Inc. Equity Warrant stock resilient to inflationEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Why analysts remain bullish on Liminatus Pharma Inc. Equity Warrant stockMarket Rally & Real-Time Volume Analysis Alerts - newser.com
Using Ichimoku Cloud for Liminatus Pharma Inc. Equity Warrant technicalsWeekly Market Summary & Free Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-09-29 16:25:27 - newser.com
Quantitative breakdown of Liminatus Pharma Inc. recent moveJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Momentum divergence signals in Liminatus Pharma Inc. chartJuly 2025 Final Week & Free Community Consensus Stock Picks - newser.com
Is Liminatus Pharma Inc. Equity Warrant stock a bargain at current levels2025 Market WrapUp & Community Trade Idea Sharing - newser.com
Liminatus Pharma Inc. Equity Warrant’s volatility index tracking explained2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
How hedge fund analytics apply to Liminatus Pharma Inc. Equity Warrant stockQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com
Can machine learning forecast Liminatus Pharma Inc. Equity Warrant recoveryQuarterly Earnings Summary & Verified Swing Trading Watchlist - newser.com
Published on: 2025-09-29 09:28:56 - newser.com
Using AI based signals to follow Liminatus Pharma Inc. Equity WarrantQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
Published on: 2025-09-29 05:36:39 - newser.com
Is Liminatus Pharma Inc Equity Warrant a good long term investmentEarnings Volatility Patterns & Collaborate and Win Together - earlytimes.in
What drives GasLog Partners LP stock priceAI-Driven Market Analysis & Outstanding Wealth Building - earlytimes.in
Liminatus Pharma Inc (LIMN) 재무 분석
Liminatus Pharma Inc (LIMN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):